Time is of the Essence in Fighting Antimicrobial Resistance
Antimicrobial resistance (AMR) was declared a top 10 global public health threat in 20191, however, recent reports reveal that actions and investments are still needed to prevent a potential AMR public health crisis.
“AMR is with us now, killing people. If we don’t take action now, a dreadful post-antibiotic apocalypse.”
— Dame Sally Davies – UK ARM Envoy
“There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation."
— United Nations Interagency Coordination Group
How Could a Complete Solution for Antimicrobial Stewardship Benefit Your Facility?
bioMérieux provides the most complete solution to support antimicrobial stewardship (AMS) initiatives. We offer a unique and comprehensive range of actionable diagnostics, advanced analytics, consultancy services and educational modules that enable the lab and clinicians to provide earlier, optimised and data-driven therapy for better patient management and a responsible use of antibiotics.
Hear how bioMérieux's unique end-to-end solution enables optimised use of diagnostics for optimised therapy along the entire patient care pathway.
INITIATION ZONE – DIAGNOSTICS SUPPORT EARLY DECISION-MAKING
Does the patient need antibiotics? If so, which one?
Discover the untapped potential of diagnostic data. Connect and leverage diagnostic results from end-to-end to support therapeutic decisions that contribute to patient outcomes. When a patient presents at a healthcare system with infectious disease symptoms, bioMérieux's integrated diagnostic and data-driven solutions can help avoid unnecessary antibiotic use, support empiric treatment, and identify pathogens to support evidence-based decision-making.
Want to Reduce Time to Effective Treatment?
Activate Antimicrobial Stewardship with Diagnostic-Driven Data During Initiation
bioMérieux is pushing the boundaries of microbiology, giving patient results sooner and making those results more meaningful with advanced analytics and collaborative tools, like antibiograms.
Learn how to activate AMS during antibiotic therapy initiation with CLARION™.
OPTIMISATION ZONE – DIAGNOSTICS DRIVE TREATMENT ADJUSTMENTS
Is there a better antibiotic for the patient?
Fast and actionable diagnostics and data technology enable clinicians to modify therapy— escalating, de-escalating or changing antibiotics to ensure effective treatment of the bacteria responsible for the infection. bioMérieux's complete solution, used in a team approach, can help guide patient management—including therapy decisions.
Want to Activate Better Patient Outcomes?
Accelerate Antimicrobial Stewardship with Integrated Diagnostic Solutions During Optimisation
Fast and actionable diagnostics and data technology enable clinicians to modify therapy to ensure effective treatment of the bacteria responsible for the infection.
bioMérieux's integrated solutions for AMS foster seamless partnership from the laboratory to frontline patient care. Learn how to accelerate AMS during antibiotic therapy optimisation with VITEK® REVEAL™.
DISCONTINUATION ZONE – DIAGNOSTICS HELP TO SAFELY END TREATMENT
When can the antibiotic treatment be safely discontinued?
Antibiotics should be discontinued as soon as safely possible to avoid potential side effects and the emergence of resistant bacteria. bioMérieux's diagnostic solutions offer clinicians objective information that, along with clinical assessment, help them decide if and they can safely stop antibiotic treatment.
Want Shorter Hospital Stays and Reduced Healthcare-Associated Costs?
Advance Antimicrobial Stewardship with Diagnostic Evidence During Discontinuation
bioMérieux offers the most complete diagnostic solution to support patient care, including the safe discontinuation of antibiotic treatment.
Listen to Dr. Ben Mitchell discuss how to advance AMS during therapy discontinuation with rapid diagnostics and data using the BIOFIRE® Meningitis/Encephalitis panel.
Ready to Drive Your Stewardship Initiatives Forward?
Let's Connect! Fill out the form below, and a local bioMérieux expert will reach out to discuss what AMS solutions could help you achieve your goals.
bioMérieux’s Diverse Resources Support Your Stewardship Initiatives
Discover how our rapid diagnostic solutions can support timely detection and identification for optimised antibiotic therapy and improved patient outcomes.
Explore on-demand education, timely thought leadership, and diagnostic solutions supporting the fight against AMR.
Thought-provoking articles on scientific news, advancements, important issues, and much more.
1 WHO. Antimicrobial resistance. Who.int. Published October 13, 2020. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance